| Turquia | Áustria | Espanha | |
| Terapia Intravenosa de Resveratrol | de $200 | de $600 | de $400 |
A Bookimed não adiciona taxas extras aos preços de Terapia Intravenosa de Resveratrol. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais em Terapia Intravenosa de Resveratrol e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de Terapia Intravenosa de Resveratrol.
Dr. Piyaphon On-phoon specializes in anti-aging and regenerative medicine. He also provides chelation therapy and immune therapy with high-dose vitamin and nutrition infusions.
He treats erectile dysfunction and offers hormone replacement therapy. He provides preventive care for noncommunicable diseases such as hypertension, atherosclerosis, diabetes, and dyslipidemia. He also treats skin diseases and offers aesthetic procedures using laser, HIFU, Thermage, Botox, and filler injections.
Professor İlhan Mavioğlu is a cardiovascular surgeon and leads the Cardiovascular Surgery Outpatient Clinic. His focus areas include total arterial revascularization. He performs minimally invasive off-pump anaortic CABG (MACAB) and MIDCAB. He also performs awake carotid surgery. He manages peripheral vascular and endovascular procedures, including chimney TEVAR, EVAR, BEVAR, FEVAR, PEVAR, and CERAB, and handles related complications.
Education and accreditation: MD, Hacettepe University (1990). Cardiovascular surgery specialization, Dışkapı Yıldırım Beyazıt Training and Research Hospital (1996). Associate Professor, Mersin University (2003). Professor, Düzce University (2012). Certificates include endovascular training (2011) and Robotic Mitral Valve Repair (2014).
Publications include J Clin Med (2023), Innovations (2023), J Card Surg (2022), and Asian Cardiovasc Thorac Ann (2019). He also authored a 12-year infrarenal AAA mortality report (1999). He has been a member of national and European cardiovascular and vascular societies since 1992.